Cessation of Smoking Trial in the Emergency Department
COSTED
2 other identifiers
interventional
972
1 country
1
Brief Summary
The Cessation of Smoking Trial in the Emergency Department (CoSTED) is an National Institute for Health Research (NIHR) Health Technology Assessment (HTA) funded randomised controlled trial (RCT). The research question is "in people attending the Emergency Department who smoke, does a brief intervention (including the provision of an electronic cigarette (e-cigarette) and referral to stop smoking services) increase smoking cessation in comparison with usual care and is it cost effective?" The trial includes an internal pilot, health economic evaluation and process evaluation. The primary outcome is smoking cessation, self-reported as continuous smoking abstinence, biochemically validated by carbon monoxide monitoring with cut off of ≥8ppm. The sample size is 972 (486 in intervention and control) across 6 sites.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2021
CompletedFirst Posted
Study publicly available on registry
April 22, 2021
CompletedStudy Start
First participant enrolled
January 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedResults Posted
Study results publicly available
April 30, 2026
CompletedApril 30, 2026
December 1, 2023
1.2 years
March 26, 2021
May 1, 2025
April 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Continuous Smoking Abstinence
The primary outcome is smoking cessation, self-reported as continuous smoking abstinence, biochemically validated by carbon monoxide monitoring with cut off of ≥8ppm.This is according to the Russell standard, stated as: continuous abstinence (Russell Standard) \[ Time Frame: Six months post quit date \] Self-report of smoking not more than five cigarettes from the Quit date, supported by biochemical validation (expired air carbon monoxide)
6 months after randomisation
Secondary Outcomes (11)
7-day Point Prevalence Abstinence
6 months after randomisation
Number of Quit Attempts
6 months after randomisation
Number of Cigarettes Per Day
6 months after randomisation
Nicotine Dependence
6 months after randomisation
Number of Times Using an E-cigarette Per Day
6 months after randomisation
- +6 more secondary outcomes
Study Arms (2)
CoSTED Intervention
EXPERIMENTALCoSTED is an opportunistic smoking cessation intervention comprising three elements: 1. brief smoking cessation advice 2. the provision of an electronic cigarette (e-cigarette) and training in its use 3. referral to stop-smoking services
Treatment as Usual
NO INTERVENTIONSignposting to NHS smoking cessation services through provision of written information about local services.
Interventions
Brief smoking cessation advice, the provision of an e-cigarette starter kit and training in its use, and referral to stop smoking services.
Eligibility Criteria
You may qualify if:
- Adults ≥18 years old who are current daily tobacco smokers
- Current daily tobacco smoker (self-reporting smoking of at least one cigarette per day)
- Attending the ED for medical treatment (or accompanying a patient attending for medical treatment)
- Submitting an expired carbon monoxide (CO) breath test reading of more than ≥8 parts per million (ppm).
You may not qualify if:
- Requiring immediate medical treatment as defined by the treating clinician.
- In police custody.
- Known history of allergy to nicotine replacement products.
- Currently defined as dual users - already using an e-cigarette daily as well as smoking conventional cigarettes.
- Without the capacity to give informed consent for participation in the study
- Have taken part in the CoSTED trial already
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Norfolk and Norwich University Hospitals NHS Foundation Trust
Norwich, Norfolk, NR4 7UY, United Kingdom
Related Publications (4)
Notley C, Clark L, Belderson P, Ward E, Clark AB, Parrott S, Agrawal S, Bloom BM, Boyle AA, Morris G, Gray A, Coats T, Man MS, Bauld L, Holland R, Pope I. Cessation of smoking trial in the emergency department (CoSTED): protocol for a multicentre randomised controlled trial. BMJ Open. 2023 Jan 18;13(1):e064585. doi: 10.1136/bmjopen-2022-064585.
PMID: 36657751RESULTWard E, Belderson P, Clark A, Stirling S, Clark L, Pope I, Notley C. How do people quit smoking using e-cigarettes? A mixed-methods exploration of participant smoking pathways following receiving an opportunistic e-cigarette-based smoking cessation intervention. Addiction. 2024 Dec;119(12):2185-2196. doi: 10.1111/add.16633. Epub 2024 Sep 10.
PMID: 39252616DERIVEDPope I, Clark LV, Clark A, Ward E, Belderson P, Stirling S, Parrott S, Li J, Coats T, Bauld L, Holland R, Gentry S, Agrawal S, Bloom BM, Boyle AA, Gray AJ, Morris MG, Livingstone-Banks J, Notley C. Cessation of Smoking Trial in the Emergency Department (COSTED): a multicentre randomised controlled trial. Emerg Med J. 2024 Apr 22;41(5):276-282. doi: 10.1136/emermed-2023-213824.
PMID: 38531658DERIVEDBelderson P, Ward E, Pope I, Notley C. Selecting an e-cigarette for use in smoking cessation interventions and healthcare services: findings from patient and public consultation for the COSTED trial. BMJ Open. 2024 Mar 4;14(3):e078677. doi: 10.1136/bmjopen-2023-078677.
PMID: 38443079DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Ian Pope
- Organization
- Norfolk and Norwich University Hospitals NHS Foundation Trust
Study Officials
- PRINCIPAL INVESTIGATOR
Ian Pope, MD
Norfolk and Norwich University Hospitals NHS Foundation Trust
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2021
First Posted
April 22, 2021
Study Start
January 4, 2022
Primary Completion
March 31, 2023
Study Completion
September 30, 2023
Last Updated
April 30, 2026
Results First Posted
April 30, 2026
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share
Data underlying the main trial results will be available in a public, open access repository immediately following publication of the major findings of the study. Details of the repository and a persistent URL will be provided on publication of the main results. Study protocol, statistical analysis plan, informed consent form, and other documents will also be available.